IL-5-producing Group 2 innate lymphoid cells promote T cell-independent IgA production in cooperation with eosinophils
Intestinal bacteria play a critical role in the regulation of the host immune system and an imbalance in the intestinal bacterial composition induces various host diseases. Therefore, maintaining a balance in the intestinal bacterial composition is crucial for health. Immunoglobulin A (IgA), produced through T cell-dependent and T cell-independent (TI) pathways, is essential for host defense against pathogen invasion and maintaining the balance of intestinal symbiotic bacteria. Interleukin (IL)-5 is constitutively produced by Group 2 innate lymphoid cells (ILC2s) and plays a critical role in the survival and proliferation of B cells and eosinophils. Here, we show the role of IL-5-producing ILC2s in intestinal TI IgA production at steady state using T cell receptor α deficient mice. In this mouse model, ILC2s increased fecal TI IgA levels in a non-inflammatory state in an IL-5-dependent manner. The administration of recombinant IL-33 (rIL-33) increased the amount of TI IgA production, accompanied by an increase in the number of IL-5-producing ILC2s in the large intestine. In addition, rIL-33 treatment increased IL-5-dependent IgA+ cells in isolated lymphoid follicles, the site of TI IgA production. Furthermore, eosinophils recruited by ILC2s were required for the maximal production of IgA in the TI pathway. Moreover, IL-5 increased the frequency of TI IgA-binding intestinal bacteria and was involved in the maintenance of intestinal bacterial composition. These findings indicate that IL-5-producing ILC2s together with eosinophils contribute to TI IgA production. In addition to their role in TI IgA production, IL-5-producing ILC2s may contribute to the homeostasis of intestinal commensal bacteria.
Authors
- Kiyoshi Takatsu
- Yoshinori Nagai (ORCID: https://orcid.org/0000-0002-5754-5357)
- T Nagai (ORCID: https://orcid.org/0000-0003-1603-2480)
- Tsutomu Yanagibashi (ORCID: https://orcid.org/0000-0002-8112-2354)
- Masashi Ikutani
- Makoto Arita (ORCID: https://orcid.org/0000-0001-9902-0463)
- Yasuharu Watanabe
Institutions
- Kanazawa University (JP)
- Hiroshima University (JP)
- Keio University (JP)
- Toyama Prefectural Institute for Pharmaceutical Research (JP)
- Keio University Hospital (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- Toyama Prefectural University (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- International Immunology
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1093/intimm/dxae070
- Citations
- 3
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Tamura Science and Technology Foundation
- Japan Society for the Promotion of Science